Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Rectal Cancer, Surgery Indication. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Belgium, Canada, China, France, Italy +1
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Low Powered Colorectal Anastomosis After Rectal Excision : An Exploratory, Observational, Prospective, IDEAL Stage 2b International Cohort Study (OASIS)
Overview
The objectiive of this prospective, international cohort is to compare two anastomotic techniques (DS vs TTSS) by collecting data during the surgery, and postoperatively (morbidity and functional outcomes). The choice of technique is left to the discretion of the surgeon based on her/his practices.
Detailed description
There are a variety of available anastomotic techniques to facilitate restorative surgery following total mesorectal excision (TME) for rectal cancer. However, there is no good quality evidence demonstrating the superiority of any single technique with regards to the potential sequalae of restorative surgery including anastomotic leakage and functional impact. Double-stapled anastomotic technique (DST) for colorectal anastomosis is the most widely used technique worldwide. An alternative to DST is the hand-sewn coloanal anastomotic (CAA) technique, which is traditionally reserved for patients with ultralow rectal tumours requesting restorative surgery or in cases of technical difficulties whereby a low colorectal anastomosis is converted to a coloanal anastomosis. More recently, the Transanal Transection and Single Staple anastomosis (TTSS) technique has been described. The TTSS technique has the potential to mitigate the difficulties encountered with DST and the potential complications and long-term functional sequalae encountered with handsewn anastomosis. Moreover, powered mechanical circumferential staplers represent a significant advancement in colorectal surgery, particularly in performing anastomosis following rectal excision. These devices are designed to provide consistent staple formation and controlled tissue compression, reducing the variability associated with manual stapling.
AL has a significant impact on clinical, patient-reported, and oncological outcomes. To mitigate the impact of AL a diverting stoma is routinely used to protect the distal anastomosis and facilitate anastomotic healing, with these stomas reversed once the integrity and patency of the distal anastomosis is confirmed. However, there is a significant complication profile associated with the routine use of diverting stomas. Through the incorporation of appropriate pre-operative risk stratification and careful post-operative surveillance a selective stoma strategy is associated with good clinical and functional outcomes.
The use of Double-stapled anastomotic technique (DST) or Transanal Transection Single-Stappled (TTSS) by laparoscopic or robotic approach, using or not a defunctionning stoma could not be separately tested in randomized trial.
In this exploratory, observational, prospective, IDEAL stage 2b International cohort study, we aim to include 400 patients with resection rectal and low powered colorectal anastomosis.
Primary outcome measures
- To assess and compare the rate of anastomotic leakage at 1 month after rectal excision between double and single-stapling low colorectal anastomosis using advanced powered stapler [Time frame: From the surgery to one month]
Secondary outcome measures (11)
- Overall morbidity and mortality rates at 1 month [Time frame: At 1 month after the end of the surgery]
- The rate of anastomotic leakage at 6 and 12 months after rectal surgery; [Time frame: At 12 month after the end of the surgery]
- Quality of life with QLQ C30 questionnaire [Time frame: At 1, 6 and 12 months after rectal surgery]
- Quality of life with QLQ CR29 questionnaire [Time frame: At 1,6 and 12 months after rectal surgery]
- Qualiy of life with EQ5D-5L [Time frame: At 1, 6 and 12 months after rectal surgery]
- Digestive function with LARS score [Time frame: At 1, 6 and 12 months after rectal surgery]
- Anal Incontinence with Wexner score ( or Vaizey score) [Time frame: At 1,6 and 12 months after rectal surgery]
- Female Sexual Function Index (FSFI) scale scores [Time frame: At 1, 6 and 12 months after rectal surgery]
- International Index of Erectile Function (IIEF)-5 [Time frame: At 1,6 and 12 months after rectal surgery]
- International Prostate Symptom Score (IPSS) [Time frame: At 1, 6 and 12 months after surgery]
- Predictive factors for anastomotic fistula [Time frame: From the surgery to 12 months]
Eligibility criteria
Inclusion criteria
- Age ≥ 18
- Patients with rectal cancer lower than 12 cm from the anal verge requiring either a stapling anastomosis below 7 cm from the anal verge,
- Patients with powered mechanical anastomosis (INTOCARE devices)
- Patients with no metastasis
- Patients operated on by mini-invasive rectal excision (laparoscopic, robotic or TaTME);
- Patients with or without defunctioning ileostomy;
- Patients with or without neoadjuvant treatment;
- Patient who benefits by medicare system;
- Signed and dated informed consent
Exclusion criteria
- Patients with handsewn anastomosis
- Patients with perforated rectal cancer or preoperative pelvic sepsis ;
- Patients with inflammatory bowel disease;
- Patients operated on in emergency ;
- Patients with extended-TME or pelvic exenteration;
- Pregnancy or breast feeding period
- Legal incapacity or physical, psychological social or geographical status interfering with the patient's ability to agree to participate in the study
- Persons deprived of liberty or under guardianship
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 8 centers
- CHU de Besançon — Besançon
- Bordeaux Colorectal Institute — Bordeaux
- Hôpital Bicêtre APHP — Le Kremlin-Bicêtre
- CHU de Lyon — Lyon
- Gp Hospitalier Diaconesses Croix St Simon — Paris
- Hôpital Européen Georges Pompidou APHP — Paris
- Hôpital Saint Antoine APHP — Paris
- Hôpital Charles Nicolle — Rouen
Canada · 2 centers
- Hôpital Universitaire McGill — Montreal
- CHU de Quebec — Québec
Spain · 2 centers
- Hôpital General universitaire Madrid — Madrid
- Hôpital Universitaire de Vigo — Vigo
Belgium · 1 center
- Hôpital Universitaire de Belgique — Leuven
China · 1 center
- Hôpital Universitaire de Shanghai — Shanghai
Italy · 1 center
- Policlinique Universitaire Gemelli — Roma
Identifiers
NCT: NCT07146334 · B.C.I. 2025/01